GLP-1 supplements are dietary products designed to emulate the effects of glucagon-like peptide-1, a crucial hormone in regulating blood sugar and appetite. They are gaining significant attention as potential non-prescription alternatives to popular GLP-1 receptor agonist drugs, which are FDA-approved for managing type 2 diabetes and obesity. The primary demographic for these supplements includes individuals seeking to improve glucose control and manage weight, especially those with metabolic disorders. However, it's vital to understand that GLP-1 supplements are not the same as prescription medications; they lack the same rigorous FDA approval and extensive clinical trial data. While they may offer accessible options for lifestyle and metabolic support as part of a broader wellness plan, there are considerable caveats and risks. Regulatory bodies, including the FDA, have raised alarms about misleading claims and unapproved GLP-1-related products. The scientific evidence supporting the efficacy and safety of many supplement ingredients is often weak or absent, and their full risk profiles are largely unknown. Misleading marketing, implying equivalence to prescription drugs, is a significant concern. For individuals with serious metabolic conditions, relying on unproven supplements can delay effective, evidence-based care. Consumers should approach GLP-1 supplements with caution, prioritize transparent labeling, third-party testing, and always consult a healthcare professional, especially if they have existing medical conditions or are on other medications.